PEREGRINE VENTURES REALIZES USD 500 MILLION EXIT FROM CARTIHEAL FOLLOWING FDA APPROVAL OF IMPLANT FOR TREATMENT OF CARTILAGE AND OSTEOCHONDRAL DEFECTS USA – English USA – English
“Upon first hearing of CartiHeal’s groundbreaking technology, we knew of the company’s immense potential. In fact, we were CartiHeal’s first investors,” said Peregrine’s Co-founder and …
